Ann: SPL7013 nasal spray for COVID19 development update, page-64

I have not been active on this SPL thread for quite some time due to the repetitive nature of discussion and lack of meaningful execution from management.

Still holding the stock and still big on the science - I however have no faith in Jackie's ability to take this product to market. If they licence it to someone like Sanofi, or better yet Johnson & Johnson (as they have a massive OTC product range), with associated regulatory approvals, this will take off.

Today is more pivotal than yesterday, if this kicks on and goes up rather than pulling back as it usually does after an announcement, the market may actually like this news. Could test 12 month highs or even the highs since I've held it (I think it touched $1.66 on one fine day).

Any real updates from the Dep trials with response rates and/or additional Dep licenses with payments would be great.

Big believer in SPL, but its been a very long wait, and will probably still be a while until it reaches its potential.

But happy to wait for it.